Featured

Initial Results of Hyalex Freestyle Knee Implant First-in-Human Clinical Studies to be Presented at the ISAKOS Congress 2025

• News, Press
• 05.29.25

Featured

Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant

• News, Press
• 05.20.25

Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System

• News, Press
• 04.21.24

Featured

Hyalex Orthopaedics Appoints Thomas Vail, M.D., as Chief Medical Officer and Names Adam Gridley to Board of Directors

• News, Press
• 04.15.24

Featured

Hyalex VP of R&D Mary Beth Schmidt presents at ICRS World Congress 2022

• News, Press
• 04.14.22

Hyalex Receives ISO 13485 Certification

• News, Press
• 12.13.21